PBE vs. GNOM ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Global X Genomics & Biotechnology ETF (GNOM)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$69.92
Average Daily Volume
5,515
30
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$10.43
Average Daily Volume
38,019
39
Performance
Period | PBE | GNOM |
---|---|---|
30 Days | 1.77% | -4.76% |
60 Days | 0.10% | -6.53% |
90 Days | 2.35% | -6.17% |
12 Months | 27.79% | 6.77% |
PBE Overweight 21 Positions Relative to GNOM
PBE Underweight 30 Positions Relative to GNOM
Symbol | Grade | Weight | |
---|---|---|---|
RNA | B | -5.9% | |
BNTX | D | -4.68% | |
RARE | D | -4.38% | |
A | F | -3.79% | |
SRPT | F | -3.74% | |
LEGN | F | -3.67% | |
CRSP | D | -3.36% | |
ARWR | C | -3.28% | |
BEAM | C | -2.98% | |
NTLA | F | -2.67% | |
RCKT | F | -2.65% | |
GILD | C | -2.5% | |
TXG | F | -2.34% | |
VRTX | B | -2.3% | |
MRNA | F | -1.82% | |
VIR | C | -1.58% | |
PACB | D | -1.2% | |
FLGT | F | -0.8% | |
SANA | F | -0.74% | |
RGNX | D | -0.72% | |
VERV | D | -0.63% | |
ALLO | D | -0.57% | |
QURE | C | -0.47% | |
EDIT | F | -0.46% | |
TSVT | F | -0.41% | |
CRBU | D | -0.36% | |
PSTX | B | -0.35% | |
LYEL | F | -0.26% | |
BLUE | F | -0.15% | |
SCLX | F | -0.02% |
PBE: Top Represented Industries & Keywords
GNOM: Top Represented Industries & Keywords